TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
58,028
|
8,330
|
27,318 |
| Financial expenses |
0
|
9
|
75 |
| Earnings before taxes |
53,169
|
24,509
|
34,782 |
| EBITDA |
51,276
|
24,050
|
41,417 |
| Total assets |
125,201
|
71,480
|
53,706 |
| Current assets |
103,960
|
48,813
|
24,474 |
| Current liabilities |
61,300
|
11,137
|
552 |
| Equity capital |
63,901
|
60,342
|
53,154 |
| - share capital |
30
|
33
|
36 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.0%
|
84.4%
|
99.0% |
| Turnover per employee |
19,343
|
2,777
|
9,106 |
| Profit as a percentage of turnover |
91.6%
|
294.2%
|
127.3% |
| Return on assets (ROA) |
42.5%
|
34.3%
|
64.9% |
| Current ratio |
169.6%
|
438.3%
|
4433.7% |
| Return on equity (ROE) |
83.2%
|
40.6%
|
65.4% |
| Change turnover |
49,656
|
-16,775
|
8,808 |
| Change turnover % |
593%
|
-67%
|
48% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
200% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.